Global Anti-infective Agents Market Research Report 2024
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
According to Mr Accuracy reports’s new survey, global Anti-infective Agents market is projected to reach US$ 168440 million in 2034, increasing from US$ 125640 million in 2024, with the CAGR of 4.2% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-infective Agents market research.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-infective Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson
Segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Segment by Application
Hospital Use
Clinic Use
Household
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anti-infective Agents report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Table of Content
1 Anti-infective Agents Market Overview
1.1 Product Overview and Scope of Anti-infective Agents
1.2 Anti-infective Agents Segment by Type
1.2.1 Global Anti-infective Agents Market Value Comparison by Type (2024-2034)
1.2.2 Antibacterial Drugs
1.2.3 Antifungal Drugs
1.2.4 Antiviral Drugs
1.3 Anti-infective Agents Segment by Application
1.3.1 Global Anti-infective Agents Market Value by Application: (2024-2034)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Anti-infective Agents Market Size Estimates and Forecasts
1.4.1 Global Anti-infective Agents Revenue 2018-2034
1.4.2 Global Anti-infective Agents Sales 2018-2034
1.4.3 Global Anti-infective Agents Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Anti-infective Agents Market Competition by Manufacturers
2.1 Global Anti-infective Agents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-infective Agents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-infective Agents Average Price by Manufacturers (2018-2023)
2.4 Global Anti-infective Agents Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Anti-infective Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-infective Agents, Product Type & Application
2.7 Anti-infective Agents Market Competitive Situation and Trends
2.7.1 Anti-infective Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-infective Agents Players Market Share by Revenue
2.7.3 Global Anti-infective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-infective Agents Retrospective Market Scenario by Region
3.1 Global Anti-infective Agents Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Anti-infective Agents Global Anti-infective Agents Sales by Region: 2018-2034
3.2.1 Global Anti-infective Agents Sales by Region: 2018-2023
3.2.2 Global Anti-infective Agents Sales by Region: 2024-2034
3.3 Global Anti-infective Agents Global Anti-infective Agents Revenue by Region: 2018-2034
3.3.1 Global Anti-infective Agents Revenue by Region: 2018-2023
3.3.2 Global Anti-infective Agents Revenue by Region: 2024-2034
3.4 North America Anti-infective Agents Market Facts & Figures by Country
3.4.1 North America Anti-infective Agents Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Anti-infective Agents Sales by Country (2018-2034)
3.4.3 North America Anti-infective Agents Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-infective Agents Market Facts & Figures by Country
3.5.1 Europe Anti-infective Agents Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Anti-infective Agents Sales by Country (2018-2034)
3.5.3 Europe Anti-infective Agents Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-infective Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-infective Agents Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Anti-infective Agents Sales by Country (2018-2034)
3.6.3 Asia Pacific Anti-infective Agents Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-infective Agents Market Facts & Figures by Country
3.7.1 Latin America Anti-infective Agents Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Anti-infective Agents Sales by Country (2018-2034)
3.7.3 Latin America Anti-infective Agents Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-infective Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-infective Agents Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Anti-infective Agents Sales by Country (2018-2034)
3.8.3 Middle East and Africa Anti-infective Agents Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-infective Agents Sales by Type (2018-2034)
4.1.1 Global Anti-infective Agents Sales by Type (2018-2023)
4.1.2 Global Anti-infective Agents Sales by Type (2024-2034)
4.1.3 Global Anti-infective Agents Sales Market Share by Type (2018-2034)
4.2 Global Anti-infective Agents Revenue by Type (2018-2034)
4.2.1 Global Anti-infective Agents Revenue by Type (2018-2023)
4.2.2 Global Anti-infective Agents Revenue by Type (2024-2034)
4.2.3 Global Anti-infective Agents Revenue Market Share by Type (2018-2034)
4.3 Global Anti-infective Agents Price by Type (2018-2034)
5 Segment by Application
5.1 Global Anti-infective Agents Sales by Application (2018-2034)
5.1.1 Global Anti-infective Agents Sales by Application (2018-2023)
5.1.2 Global Anti-infective Agents Sales by Application (2024-2034)
5.1.3 Global Anti-infective Agents Sales Market Share by Application (2018-2034)
5.2 Global Anti-infective Agents Revenue by Application (2018-2034)
5.2.1 Global Anti-infective Agents Revenue by Application (2018-2023)
5.2.2 Global Anti-infective Agents Revenue by Application (2024-2034)
5.2.3 Global Anti-infective Agents Revenue Market Share by Application (2018-2034)
5.3 Global Anti-infective Agents Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Inc. Anti-infective Agents Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories Anti-infective Agents Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Gilead Sciences, Inc.
6.3.1 Gilead Sciences, Inc. Corporation Information
6.3.2 Gilead Sciences, Inc. Description and Business Overview
6.3.3 Gilead Sciences, Inc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Gilead Sciences, Inc. Anti-infective Agents Product Portfolio
6.3.5 Gilead Sciences, Inc. Recent Developments/Updates
6.4 Bristol-Myers Squibb Co.
6.4.1 Bristol-Myers Squibb Co. Corporation Information
6.4.2 Bristol-Myers Squibb Co. Description and Business Overview
6.4.3 Bristol-Myers Squibb Co. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Co. Anti-infective Agents Product Portfolio
6.4.5 Bristol-Myers Squibb Co. Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Corporation Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck & Co., Inc. Anti-infective Agents Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Bayer Healthcare AG
6.6.1 Bayer Healthcare AG Corporation Information
6.6.2 Bayer Healthcare AG Description and Business Overview
6.6.3 Bayer Healthcare AG Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bayer Healthcare AG Anti-infective Agents Product Portfolio
6.6.5 Bayer Healthcare AG Recent Developments/Updates
6.7 AstraZeneca Plc.
6.6.1 AstraZeneca Plc. Corporation Information
6.6.2 AstraZeneca Plc. Description and Business Overview
6.6.3 AstraZeneca Plc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Plc. Anti-infective Agents Product Portfolio
6.7.5 AstraZeneca Plc. Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Corporation Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boehringer Ingelheim Anti-infective Agents Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novartis AG Anti-infective Agents Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Astellas Pharma, Inc.
6.10.1 Astellas Pharma, Inc. Corporation Information
6.10.2 Astellas Pharma, Inc. Description and Business Overview
6.10.3 Astellas Pharma, Inc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Astellas Pharma, Inc. Anti-infective Agents Product Portfolio
6.10.5 Astellas Pharma, Inc. Recent Developments/Updates
6.11 GlaxoSmithKline Plc.
6.11.1 GlaxoSmithKline Plc. Corporation Information
6.11.2 GlaxoSmithKline Plc. Anti-infective Agents Description and Business Overview
6.11.3 GlaxoSmithKline Plc. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline Plc. Anti-infective Agents Product Portfolio
6.11.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.12 Alcon Pharmaceuticals Ltd.
6.12.1 Alcon Pharmaceuticals Ltd. Corporation Information
6.12.2 Alcon Pharmaceuticals Ltd. Anti-infective Agents Description and Business Overview
6.12.3 Alcon Pharmaceuticals Ltd. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Alcon Pharmaceuticals Ltd. Anti-infective Agents Product Portfolio
6.12.5 Alcon Pharmaceuticals Ltd. Recent Developments/Updates
6.13 Sanofi-Aventis S.A.
6.13.1 Sanofi-Aventis S.A. Corporation Information
6.13.2 Sanofi-Aventis S.A. Anti-infective Agents Description and Business Overview
6.13.3 Sanofi-Aventis S.A. Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sanofi-Aventis S.A. Anti-infective Agents Product Portfolio
6.13.5 Sanofi-Aventis S.A. Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Anti-infective Agents Description and Business Overview
6.14.3 Johnson & Johnson Anti-infective Agents Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Johnson & Johnson Anti-infective Agents Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-infective Agents Industry Chain Analysis
7.2 Anti-infective Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-infective Agents Production Mode & Process
7.4 Anti-infective Agents Sales and Marketing
7.4.1 Anti-infective Agents Sales Channels
7.4.2 Anti-infective Agents Distributors
7.5 Anti-infective Agents Customers
8 Anti-infective Agents Market Dynamics
8.1 Anti-infective Agents Industry Trends
8.2 Anti-infective Agents Market Drivers
8.3 Anti-infective Agents Market Challenges
8.4 Anti-infective Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figure
List of Tables
Table 1. Global Anti-infective Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-infective Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-infective Agents Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-infective Agents Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-infective Agents Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-infective Agents Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-infective Agents Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-infective Agents Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-infective Agents, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Anti-infective Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-infective Agents, Product Type & Application
Table 12. Global Key Manufacturers of Anti-infective Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-infective Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-infective Agents as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-infective Agents Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Anti-infective Agents Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-infective Agents Sales Market Share by Region (2018-2023)
Table 19. Global Anti-infective Agents Sales by Region (2024-2034) & (K Units)
Table 20. Global Anti-infective Agents Sales Market Share by Region (2024-2034)
Table 21. Global Anti-infective Agents Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-infective Agents Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-infective Agents Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Anti-infective Agents Revenue Market Share by Region (2024-2034)
Table 25. North America Anti-infective Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Anti-infective Agents Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-infective Agents Sales by Country (2024-2034) & (K Units)
Table 28. North America Anti-infective Agents Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-infective Agents Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Anti-infective Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Anti-infective Agents Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-infective Agents Sales by Country (2024-2034) & (K Units)
Table 33. Europe Anti-infective Agents Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-infective Agents Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Anti-infective Agents Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Anti-infective Agents Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-infective Agents Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Anti-infective Agents Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-infective Agents Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-infective Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Anti-infective Agents Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-infective Agents Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Anti-infective Agents Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-infective Agents Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anti-infective Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Anti-infective Agents Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-infective Agents Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Anti-infective Agents Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-infective Agents Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Anti-infective Agents Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-infective Agents Sales (K Units) by Type (2024-2034)
Table 52. Global Anti-infective Agents Sales Market Share by Type (2018-2023)
Table 53. Global Anti-infective Agents Sales Market Share by Type (2024-2034)
Table 54. Global Anti-infective Agents Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-infective Agents Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Anti-infective Agents Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-infective Agents Revenue Market Share by Type (2024-2034)
Table 58. Global Anti-infective Agents Price (USD/Unit) by Type (2018-2023)
Table 59. Global Anti-infective Agents Price (USD/Unit) by Type (2024-2034)
Table 60. Global Anti-infective Agents Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-infective Agents Sales (K Units) by Application (2024-2034)
Table 62. Global Anti-infective Agents Sales Market Share by Application (2018-2023)
Table 63. Global Anti-infective Agents Sales Market Share by Application (2024-2034)
Table 64. Global Anti-infective Agents Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-infective Agents Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Anti-infective Agents Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-infective Agents Revenue Market Share by Application (2024-2034)
Table 68. Global Anti-infective Agents Price (USD/Unit) by Application (2018-2023)
Table 69. Global Anti-infective Agents Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Inc. Corporation Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Inc. Anti-infective Agents Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Abbott Laboratories Anti-infective Agents Product
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Gilead Sciences, Inc. Corporation Information
Table 81. Gilead Sciences, Inc. Description and Business Overview
Table 82. Gilead Sciences, Inc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Gilead Sciences, Inc. Anti-infective Agents Product
Table 84. Gilead Sciences, Inc. Recent Developments/Updates
Table 85. Bristol-Myers Squibb Co. Corporation Information
Table 86. Bristol-Myers Squibb Co. Description and Business Overview
Table 87. Bristol-Myers Squibb Co. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bristol-Myers Squibb Co. Anti-infective Agents Product
Table 89. Bristol-Myers Squibb Co. Recent Developments/Updates
Table 90. Merck & Co., Inc. Corporation Information
Table 91. Merck & Co., Inc. Description and Business Overview
Table 92. Merck & Co., Inc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Merck & Co., Inc. Anti-infective Agents Product
Table 94. Merck & Co., Inc. Recent Developments/Updates
Table 95. Bayer Healthcare AG Corporation Information
Table 96. Bayer Healthcare AG Description and Business Overview
Table 97. Bayer Healthcare AG Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Bayer Healthcare AG Anti-infective Agents Product
Table 99. Bayer Healthcare AG Recent Developments/Updates
Table 100. AstraZeneca Plc. Corporation Information
Table 101. AstraZeneca Plc. Description and Business Overview
Table 102. AstraZeneca Plc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. AstraZeneca Plc. Anti-infective Agents Product
Table 104. AstraZeneca Plc. Recent Developments/Updates
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Boehringer Ingelheim Anti-infective Agents Product
Table 109. Boehringer Ingelheim Recent Developments/Updates
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novartis AG Anti-infective Agents Product
Table 114. Novartis AG Recent Developments/Updates
Table 115. Astellas Pharma, Inc. Corporation Information
Table 116. Astellas Pharma, Inc. Description and Business Overview
Table 117. Astellas Pharma, Inc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Astellas Pharma, Inc. Anti-infective Agents Product
Table 119. Astellas Pharma, Inc. Recent Developments/Updates
Table 120. GlaxoSmithKline Plc. Corporation Information
Table 121. GlaxoSmithKline Plc. Description and Business Overview
Table 122. GlaxoSmithKline Plc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. GlaxoSmithKline Plc. Anti-infective Agents Product
Table 124. GlaxoSmithKline Plc. Recent Developments/Updates
Table 125. Alcon Pharmaceuticals Ltd. Corporation Information
Table 126. Alcon Pharmaceuticals Ltd. Description and Business Overview
Table 127. Alcon Pharmaceuticals Ltd. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Alcon Pharmaceuticals Ltd. Anti-infective Agents Product
Table 129. Alcon Pharmaceuticals Ltd. Recent Developments/Updates
Table 130. Sanofi-Aventis S.A. Corporation Information
Table 131. Sanofi-Aventis S.A. Description and Business Overview
Table 132. Sanofi-Aventis S.A. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Sanofi-Aventis S.A. Anti-infective Agents Product
Table 134. Sanofi-Aventis S.A. Recent Developments/Updates
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Johnson & Johnson Anti-infective Agents Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-infective Agents Distributors List
Table 143. Anti-infective Agents Customers List
Table 144. Anti-infective Agents Market Trends
Table 145. Anti-infective Agents Market Drivers
Table 146. Anti-infective Agents Market Challenges
Table 147. Anti-infective Agents Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-infective Agents
Figure 2. Global Anti-infective Agents Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-infective Agents Market Share by Type in 2024 & 2034
Figure 4. Antibacterial Drugs Product Picture
Figure 5. Antifungal Drugs Product Picture
Figure 6. Antiviral Drugs Product Picture
Figure 7. Global Anti-infective Agents Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Anti-infective Agents Market Share by Application in 2024 & 2034
Figure 9. Hospital Use
Figure 10. Clinic Use
Figure 11. Household
Figure 12. Other
Figure 13. Global Anti-infective Agents Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Anti-infective Agents Market Size (2018-2034) & (US$ Million)
Figure 15. Global Anti-infective Agents Sales (2018-2034) & (K Units)
Figure 16. Global Anti-infective Agents Average Price (USD/Unit) & (2018-2034)
Figure 17. Anti-infective Agents Report Years Considered
Figure 18. Anti-infective Agents Sales Share by Manufacturers in 2024
Figure 19. Global Anti-infective Agents Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Anti-infective Agents Players: Market Share by Revenue in 2024
Figure 21. Anti-infective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Anti-infective Agents Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Anti-infective Agents Sales Market Share by Country (2018-2034)
Figure 24. North America Anti-infective Agents Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Anti-infective Agents Sales Market Share by Country (2018-2034)
Figure 28. Europe Anti-infective Agents Revenue Market Share by Country (2018-2034)
Figure 29. Germany Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Anti-infective Agents Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Anti-infective Agents Revenue Market Share by Region (2018-2034)
Figure 36. China Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Anti-infective Agents Sales Market Share by Country (2018-2034)
Figure 47. Latin America Anti-infective Agents Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Anti-infective Agents Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Anti-infective Agents Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Anti-infective Agents Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Anti-infective Agents by Type (2018-2034)
Figure 57. Global Revenue Market Share of Anti-infective Agents by Type (2018-2034)
Figure 58. Global Anti-infective Agents Price (USD/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Anti-infective Agents by Application (2018-2034)
Figure 60. Global Revenue Market Share of Anti-infective Agents by Application (2018-2034)
Figure 61. Global Anti-infective Agents Price (USD/Unit) by Application (2018-2034)
Figure 62. Anti-infective Agents Value Chain
Figure 63. Anti-infective Agents Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices